Dr. Roxanne Sholevar, MD

Dr. Sholevar practices at Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham.

Dr. Sholevar's NPI, 1912351164, was assigned on April 13, 2016. Dr. Sholevar holds Massachusetts license 282991.

Dr. Sholevar's primary practice is Brigham and Women's Hospital, at 75 Francis Street, Boston, MA 02115 in Suffolk County. The practice phone is (617) 732-5500.

Dr. Sholevar's primary practice is Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham. Dr. Sholevar is also affiliated with Dana-Farber Cancer Institute. The medical group on file is Brigham and Women's Hospital. Dmand AI also links Dr. Sholevar to 1 more hospital outpatient department and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sholevar practices, 3 sites in all. Vendor and product names are available with a free account.

Psychosomatic medicine is Dr. Sholevar's primary specialty in the NPI Registry, under taxonomy code 2084P0015X. Dr. Sholevar is licensed in Massachusetts.

CMS data shows 42 Medicare services from Dr. Sholevar across 1 procedure code in 2024, all of them office visits, for 22 Medicare patients. Medicare paid $2,937 for them. Every service was in an office.

CMS counts 22 Medicare patients who saw Dr. Sholevar in 2024. 64% of them have cancer, and 59% have anxiety. Their average risk score is 2.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sholevar's median patient age at 52, with 69% women.

In 2024, Dr. Sholevar wrote 122 Medicare Part D claims for 34 patients. 100% of them were for generic drugs. CMS names the drug for 92 of them, across 6 drugs with 11 or more claims each, at $871 in total drug cost. In 2023, CMS named 34 claims across 2 drugs.

Dr. Sholevar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sholevar as offering telehealth.

Dmand AI links 3 papers to Dr. Sholevar, published from 2023 to 2025. The most frequent topics are Critical Illness. Dr. Sholevar has published most often in J Palliat Med. Dr. Sholevar's most frequent co-authors are Yvan Beaussant, MD, MS, John Raymond Peteet, MD and Ilana Monica Braun, MD.

CMS Open Payments shows 1 general payment to Dr. Sholevar from 1 drug or device company in 2019. Food and beverage make up the largest share, 100% of the total. Otsuka Pharmaceutical Development & Commercialization, Inc. paid the most, $50.